inquiry
Leave Your Message

Featured Products for Cancer Drug Synthesis

Our flagship chemical intermediates and photoinitiators, purpose-built for pharmaceutical-grade oncology manufacturing processes.

High-cost-performance photoinitiator benzophenone for oncology drug synthesis

High-cost-performance Photoinitiator Benzophenone

Benzophenone is a classic aromatic ketone photoinitiator widely used in pharmaceutical intermediate synthesis and oncology drug research.

+ Read More
Low-chlorinated diphenylethoxyphosphine for cancer drug synthesis

Low-chlorinated Diphenylethoxyphosphine (>99%)

Diphenylethoxyphosphine (EDPP) is a widely applied phosphine compound serving as a key intermediate in cancer drug manufacturing.

+ Read More
Diphenylphosphinic Acid Diethyl Ester photoinitiator intermediate for oncology

Diphenylphosphinic Acid Diethyl Ester โ€” Photoinitiator Intermediate

An important photoinitiator intermediate supporting precision oncology compound synthesis and pharmaceutical R&D.

+ Read More
TPO-L Ethyl 2,4,6-trimethylbenzoylphenylphosphonate for cancer research

Photoinitiator TPO-L: Ethyl 2,4,6-trimethylbenzoylphenylphosphonate

TPO-L is a highly efficient liquid photoinitiator with exceptional performance in oncology-grade UV-curing and drug delivery systems.

+ Read More

Copper PCB Sheet: Transforming Oncology & Cancer Drug Synthesis

In the rapidly evolving landscape of pharmaceutical manufacturing, Copper PCB (Printed Circuit Board) Sheets have emerged as a critical enabling technology for oncology research and cancer drug synthesis. Traditionally associated with electronics, copper PCB substrates are now being leveraged in advanced pharmaceutical reactor systems, precision dosing equipment, and automated drug synthesis platforms that demand unparalleled electrical conductivity, thermal management, and chemical resistance.

The global oncology drug market is projected to exceed $500 billion USD by 2030, driven by surging demand for targeted therapies, immunotherapies, and next-generation chemotherapy agents. This explosive growth has placed unprecedented requirements on the industrial infrastructure underpinning drug synthesis โ€” and copper PCB sheets sit at the heart of this transformation.

๐Ÿ”ฌ Key Insight: Copper PCB sheets provide the precision thermal and electrical control required for continuous-flow chemistry reactors used in synthesizing oncology APIs (Active Pharmaceutical Ingredients) such as kinase inhibitors, platinum-based compounds, and monoclonal antibody conjugates.

$500B+
Global oncology drug market by 2030
98%
Copper conductivity efficiency in PCB reactor systems
10K+
Tons of photoinitiator intermediates supplied by SHUNYI
100%
Customer satisfaction & after-sales follow-up rate
๐Ÿฅ

Deep-Dive Application Scenarios in Oncology Drug Synthesis

Copper PCB sheets are no longer confined to electronics โ€” they are now mission-critical components across the full oncology pharmaceutical value chain.

๐Ÿงช

Electrochemical Synthesis of Platinum-Based Chemotherapy Agents

Cisplatin, carboplatin, and oxaliplatin โ€” cornerstone chemotherapy drugs โ€” require precise electrochemical conditions during synthesis. Copper PCB sheets provide the controlled electrode surfaces and thermal uniformity essential for achieving pharmaceutical-grade purity (>99.5%) in these platinum complex compounds.

๐Ÿ’ก

UV-Curing & Photoinitiator Systems in Drug Coating

Photoinitiators such as Benzophenone, TPO-L, and Photoinitiator 184 are integral to UV-cured drug coating processes for oncology tablets and capsules. Copper PCB-based UV lamp control circuits ensure precise light intensity and wavelength delivery, directly impacting coating uniformity and drug release profiles.

๐Ÿ”ฌ

Microfluidic Reactor Control for Kinase Inhibitor Synthesis

Targeted kinase inhibitors (e.g., imatinib, erlotinib) are synthesized via complex multi-step reactions requiring precise temperature and flow control. Copper PCB sheets embedded in microfluidic reactor control boards enable ยฑ0.1ยฐC thermal stability, critical for reproducible API synthesis at GMP scale.

๐Ÿ›ก๏ธ

Radiation Shielding & Detection Equipment PCBs

Oncology treatment facilities rely on sophisticated radiation detection and dosimetry equipment. High-density copper PCB sheets form the electronic backbone of these safety-critical systems, ensuring accurate radiation measurement for both patient treatment planning and laboratory safety compliance.

๐Ÿ’Š

Automated Dispensing & Compounding Systems

Hospital pharmacy compounding systems for oncology drugs (including hazardous cytotoxic agents) use copper PCB-based robotic controllers to ensure contamination-free, precisely dosed drug preparation โ€” protecting both patients and healthcare workers from exposure risks.

๐Ÿ“ก

Real-Time Process Analytical Technology (PAT) Integration

Copper PCB sheets serve as the signal processing backbone in PAT sensor arrays monitoring oncology drug synthesis in real time. Parameters including pH, temperature, UV absorption, and particle size are continuously tracked via PCB-integrated sensor networks, ensuring batch-to-batch consistency and regulatory compliance.

The Advantage for SHUNYI

About Us โ€” SHUNYI

Established in 2019, Suzhou Shunyida Chemical Technology Co., Ltd. is headquartered in Mudu Ancient Town, a picturesque water town in Suzhou. With over thirty employees, the company has grown significantly over the past seven years, selling nearly 10,000 tons of photoinitiator intermediates and select photoinitiators, generating sales of approximately 100 million yuan.

It ranks among the top in the industry for tax contributions and product quality. The company maintains a 100% customer satisfaction rate, zero product returns, and 100% after-sales follow-up rate โ€” making SHUNYI the trusted partner for oncology pharmaceutical manufacturers worldwide.

View More
2019
Established in
100%
Customer satisfaction
0%
Product returns
100%
After-sales follow-up
SHUNYI Chemical Technology headquarters Suzhou

Our Advantages

SHUNYI delivers unmatched value across quality, logistics, technology, and after-sales support for oncology pharmaceutical clients globally.

01
๐Ÿ†

Quality Excellence

Our company boasts a team with over a decade of expertise in photoinitiator production, maintaining close business ties with industry leaders and delivering pharmaceutical-grade purity for oncology applications.

02
๐Ÿšš

Logistics Advantage

The company maintains warehouses in Shandong and Jiangsu, ensuring timely delivery of chemical intermediates to pharmaceutical manufacturers across China and internationally.

03
๐Ÿ“ฆ

Diversified Packaging Specifications

The production base's continuous manufacturing capability can meet customers' diverse packaging specifications requirements, from laboratory scale to industrial bulk supply.

04
๐Ÿ› ๏ธ

Timely After-Sales Service

From the production of intermediates, when customers request specific substances in the product, we can promptly address them based on the raw materials and production processes at each stage.

05
๐Ÿ”ญ

Continuous Technological Advancement

The company has established a dedicated R&D department, equipped with advanced instruments including infrared spectroscopy, Agilent Shimadzu gas-liquid chromatography, and GC-MS.

06
๐Ÿ‡ช๐Ÿ‡บ

EU REACH Certification

The company successfully obtained REACH certification for TPO-L 10โ€“100-ton equipment in 2025, enabling compliant supply to European oncology and pharmaceutical manufacturers.

Certificates & Honors

The company has a professional R&D team and a professional team that has been engaged in the production of photoinitiators, epoxy resins, acryloyl chlorides and other fine chemical products for many years.

SHUNYI Chemical Certificates and Quality HonorsSHUNYI Chemical Certification Base
news

News Center

Stay updated on the latest developments in photoinitiator technology, oncology drug synthesis, and chemical innovation from SHUNYI.

2023-10-10 Application prospects of photoinitiator TPO-L in 3D printing field for oncology drug delivery

Application Prospects of Photoinitiator TPO-L in 3D Printing for Oncology Drug Delivery

Explore more
2023-10-15 TPO-L photoinitiator supports innovation in the coatings industry

TPO-L Photoinitiator Supports Innovation in the Pharmaceutical Coatings Industry

Explore more
2023-10-25 TPO-L photoinitiator successfully replaces TPO, promoting the upgrading of the UV curing industry

TPO-L Photoinitiator Successfully Replaces TPO, Promoting UV Curing Upgrades in Drug Manufacturing

Explore more
2023-10-30 The promotion and application of TPO-L photoinitiator helps enterprises achieve green transformation

TPO-L Photoinitiator Helps Oncology Enterprises Achieve Green Manufacturing Transformation

Explore more
2023-11-05 TPO-L replaces TPO, ushering in a new era of photoinitiators

TPO-L Replaces TPO, Ushering in a New Era of Photoinitiators for Cancer Drug Synthesis

Explore more
2023-11-01 Innovative application of acryloyl chloride and methacryloyl chloride in the field of adhesives

Innovative Application of Acryloyl Chloride & Methacryloyl Chloride in Oncology Adhesive Systems

Explore more

Best Sellers โ€” Complete Product Range for Oncology & Cancer Drug Synthesis

Explore our full lineup of high-purity chemical intermediates, photoinitiators, and pharmaceutical-grade reagents trusted by oncology manufacturers worldwide.

High-cost-performance photoinitiator benzophenone for oncology

High-cost-performance Photoinitiator Benzophenone

Benzophenone is a classic aromatic ketone photoinitiator for cancer drug synthesis processes.

+ Read More
Low-chlorinated diphenylethoxyphosphine for cancer drug synthesis

Low-chlorinated Diphenylethoxyphosphine (>99%)

EDPP serves as a key intermediate in pharmaceutical and oncology drug manufacturing.

+ Read More
Diphenylphosphinic Acid Diethyl Ester photoinitiator intermediate

Diphenylphosphinic Acid Diethyl Ester

An important photoinitiator intermediate for precision oncology compound synthesis.

+ Read More
Photoinitiator TPO-L Ethyl 2,4,6-trimethylbenzoylphenylphosphonate

Photoinitiator TPO-L: Ethyl 2,4,6-trimethylbenzoylphenylphosphonate

Highly efficient liquid photoinitiator for oncology-grade UV-curing systems.

+ Read More
High-purity glycidyl methacrylate GMA for cancer drug synthesis

High-purity Glycidyl Methacrylate (GMA >99.9%)

Glycidyl methacrylate (GMA), a reactive monomer critical in oncology drug delivery polymer systems.

+ Read More
Photoinitiator 184 yellow resistance for pharmaceutical coating

Photoinitiator 184 (Yellow Resistance)

Photoinitiator 184, a widely used Norrish Type I initiator for pharmaceutical-grade UV coating applications.

+ Read More
High-purity methacryloyl chloride for oncology pharmaceutical intermediates

High-purity Methacryloyl Chloride (>99%)

Methacryloyl chloride is a very important organic synthesis intermediate for oncology pharmaceutical manufacturing.

+ Read More
Medical-grade electronic-grade acryloyl chloride for cancer drug synthesis

Medical-grade / Electronic-grade Acryloyl Chloride

Acryloyl chloride is a very important organic intermediate for medical-grade and cancer drug synthesis applications.

+ Read More